Incretin example sentences

"Incretin" Example Sentences

1. Incretin therapies are currently used to treat type 2 diabetes.
2. Studies have shown that incretin hormones are essential for glucose homeostasis.
3. Incretin hormones are released in response to food intake.
4. GLP-1 and GIP are two incretin hormones that are secreted from the gut.
5. Incretin-based therapies have been shown to improve glycemic control in patients with type 2 diabetes.
6. Incretin hormones are known to have beneficial effects on glucose metabolism.
7. The incretin effect is the increase in insulin secretion in response to oral glucose.
8. Incretin-based therapies have been found to reduce the risk of hypoglycemia in patients with type 2 diabetes.
9. Incretin-based therapies are associated with weight loss and improved lipid profiles.
10. Incretin-based therapies have been shown to reduce the risk of cardiovascular events in patients with type 2 diabetes.
11. Incretin-based therapies may reduce the risk of progression to type 2 diabetes in people with prediabetes.
12. Incretin-based therapies have been found to improve glycemic control in patients with type 1 diabetes.
13. Incretin-based therapies have been associated with improved glycemic control in patients with type 2 diabetes.
14. Incretin-based therapies have been found to reduce the risk of diabetic complications in patients with type 2 diabetes.
15. Incretin-based therapies may reduce the risk of progression to type 1 diabetes in people with prediabetes.
16. Incretin-based therapies have been found to improve glycemic control and reduce the risk of hypoglycemia in patients with type 1 diabetes.
17. Incretin-based therapies have been associated with a reduction in the risk of cardiovascular events in patients with type 2 diabetes.
18. Incretin-based therapies may reduce the risk of developing microvascular complications in patients with type 2 diabetes.
19. Incretin-based therapies have been found to reduce the risk of developing macrovascular complications in patients with type 2 diabetes.
20. Incretin-based therapies have been associated with improved glycemic control and reduced risk of hypoglycemia in patients with type 2 diabetes.

Common Phases

Incretin-Based Therapies; Glucagon-Like Peptide-1 Receptor Agonists; Dipeptidyl Peptidase-4 Inhibitors; Glucagon-Like Peptide-1/Glucagon Receptor Dual Agonists; Glucagon Receptor Agonists.